FilingSEC EDGAR6-K
BIOT Appointed as Authorized Representative for CelSiege Biosciences' IN01 Cancer Immunotherapy
· SEC accepted
StageClinical-stage
Filing content
Instinct Bio Technical Company Holdings Inc. has been appointed as a non-exclusive business development representative for CelSiege Biosciences' clinical-stage cancer immunotherapy, IN01, in Japan and China.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…